SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012190
Filing Date
2016-08-11
Accepted
2016-08-11 12:28:06
Documents
43
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 634960
2 ex31-1.htm EX-31.1 12401
3 ex31-2.htm EX-31.2 12325
4 ex32-1.htm EX-32.1 5493
5 ex32-2.htm EX-32.2 5505
  Complete submission text file 0001493152-16-012190.txt   2431951

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20160630.xml EX-101.INS 328430
7 XBRL SCHEMA FILE prph-20160630.xsd EX-101.SCH 27339
8 XBRL CALCULATION FILE prph-20160630_cal.xml EX-101.CAL 37098
9 XBRL DEFINITION FILE prph-20160630_def.xml EX-101.DEF 79842
10 XBRL LABEL FILE prph-20160630_lab.xml EX-101.LAB 203343
11 XBRL PRESENTATION FILE prph-20160630_pre.xml EX-101.PRE 138284
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 161823720
SIC: 2834 Pharmaceutical Preparations